NCT00649558View on ClinicalTrials.gov

Fasting Study of Pioglitazone HCl Tablets 45 mg and Actos® Tablets 45 mg

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

February 28, 2003

Primary Completion Date

March 31, 2003

Study Completion Date

March 31, 2003

Conditions
Healthy
Interventions
DRUG

Pioglitazone HCl Tablets 45 mg

45mg, single dose fasting

DRUG

Actos® Tablets 45 mg

45mg, single dose fasting

Trial Locations (1)

58104

PRACS Institute, Ltd., Fargo

Sponsors
All Listed Sponsors
lead

Mylan Pharmaceuticals Inc

INDUSTRY

NCT00649558 - Fasting Study of Pioglitazone HCl Tablets 45 mg and Actos® Tablets 45 mg | Biotech Hunter | Biotech Hunter